Latest GlaxoSmithKline Stories
SHELTON, Conn., April 20, 2015 /PRNewswire/ -- NanoViricides, Inc., (NYSE MKT: NNVC) (the "Company"), a nanomedicine company developing anti-viral drugs, reports dramatic improvement in clinical
OTTAWA, April 17, 2015 /CNW/ - The issue: In consultation with Health Canada, GlaxoSmithKline Inc.
Study Will Include Novel Testing Using Stem Cells from Patients WASHINGTON, April 16, 2015 /PRNewswire-USNewswire/ -- The ALS Association, Harvard Stem Cell Institute, and Massachusetts
NEW YORK, April 10, 2015 /PRNewswire/ -- Zofran birth defect lawsuits continue to mount in
LONDON, April 6, 2015 /PRNewswire/ -- Report DetailsVaccines and their technology - your guide to developments, opportunities and revenuesSee what the future holds for vaccines.
The Firm’s new website, ZofranCenter.com, was launched to provide the public with updated information regarding growing litigation involving an alleged association between Zofran and birth defects.
Robert Gardner Law has created a new resource site to investigate claims following a U.S. Justice department criminal plea agreement with GlaxoSmithKline.
Zofran Lawsuits Claim Heart Birth Defects, Kidney Malformations And Other Serious Congenital Abnormalities When Taken By Pregnant Women To Control Severe Morning Sickness Chicago,
In response to this and other recent Zofran lawsuit filings, Bernstein Liebhard LLP has launched an investigation into allegations that the anti-nausea medication may cause birth defects when
In light of two recently filed Zofran lawsuits, the San Diego personal injury attorneys of The Law Office of Melinda J. Helbock, A.P.C.
- Growing in low tufty patches.